MALAT1 and neoplasm: We provide a novel discovery that LUAD patients with tumor stages harboring MALAT1 (rs3200401; CC and CT+TT) heterozygotes had a significantly associated with EGFR wild-type (Table 4), but not in all LADC patients (Table 3).